Maenpaa JU - Search Results

1

Flow cytometry: potential utility in monitoring drug effects in breast cancer.

Koester SK, Maenpaa JU, Wiebe VJ, Baker WJ, Wurz GT, Seymour RC, Koehler RE, DeGregorio MW. Koester SK, et al. Among authors: maenpaa ju. Breast Cancer Res Treat. 1994;32(1):57-65. doi: 10.1007/BF00666206. Breast Cancer Res Treat. 1994. PMID: 7819587 Review.

2

Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo.

Sipila PE, Wiebe VJ, Hubbard GB, Koester SK, Emshoff VD, Maenpaa JU, Wurz GT, Seymour RC, DeGregorio MW. Sipila PE, et al. Among authors: maenpaa ju. Eur J Cancer. 1993;29A(15):2138-44. doi: 10.1016/0959-8049(93)90049-l. Eur J Cancer. 1993. PMID: 8297653

3

Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells.

Baker WJ, Wiebe VJ, Koester SK, Emshoff VD, Maenpaa JU, Wurz GT, DeGregorio MW. Baker WJ, et al. Among authors: maenpaa ju. Breast Cancer Res Treat. 1992;24(1):43-9. doi: 10.1007/BF01832357. Breast Cancer Res Treat. 1992. PMID: 1463871

4

A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicin.

Maenpaa JU, Wurz GT, Baker WJ, Wiebe VJ, Emshoff VD, Koester SK, Seymour RC, Koehler RE, DeGregorio MW. Maenpaa JU, et al. Oncol Res. 1993;5(12):461-6. Oncol Res. 1993. PMID: 8086667

5

Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells.

Baker WJ, Maenpaa JU, Wurz GT, Koester SK, Seymour RC, Emshoff VD, Wiebe VJ, DeGregorio MW. Baker WJ, et al. Among authors: maenpaa ju. Oncol Res. 1993;5(6-7):207-12. Oncol Res. 1993. PMID: 8123940

6

Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer.

Maenpaa J, Wiebe V, Koester S, Wurz G, Emshoff V, Seymour R, Sipila P, DeGregorio M. Maenpaa J, et al. Cancer Chemother Pharmacol. 1993;32(5):396-8. doi: 10.1007/BF00735926. Cancer Chemother Pharmacol. 1993. PMID: 8339392

7

Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance.

Maenpaa J, Wiebe V, Wurz G, Koester S, Emshoff V, Seymour R, DeGregorio M. Maenpaa J, et al. Cancer Chemother Pharmacol. 1994;35(2):149-52. doi: 10.1007/BF00686638. Cancer Chemother Pharmacol. 1994. PMID: 7987992

8

Intratumoral toremifene therapy and tissue distribution in the baboon.

Wurz GT, Mäenpää JU, Hubbard GB, Cadman TB, Seymour RC, Soe L, DeGregorio MW. Wurz GT, et al. Among authors: maenpaa ju. Anticancer Drugs. 1998 Feb;9(2):181-9. doi: 10.1097/00001813-199802000-00010. Anticancer Drugs. 1998. PMID: 9510505

9

Tamoxifen for the prevention of breast cancer: no.

DeGregorio MW, Maenpaa JU, Wiebe VJ. DeGregorio MW, et al. Among authors: maenpaa ju. Important Adv Oncol. 1995:175-85. Important Adv Oncol. 1995. PMID: 7672804 Review.

10

Topical toremifene: a new approach for cutaneous melanoma?

Maenpaa J, Dooley T, Wurz G, VandeBerg J, Robinson E, Emshoff V, Sipila P, Wiebe V, Day C, DeGregorio M. Maenpaa J, et al. Cancer Chemother Pharmacol. 1993;32(5):392-5. doi: 10.1007/BF00735925. Cancer Chemother Pharmacol. 1993. PMID: 8339391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page